Keyphrases
Toll-like
100%
Low Risk
100%
Bone Marrow
100%
Receptor Expression
100%
Cytokine Expression
100%
High-risk Myelodysplastic Syndrome
100%
Myelodysplastic Syndrome
71%
Hematopoietic Stem Cells
42%
Low-intermediate Risk
42%
Transforming Growth Factor-β
28%
Clinical High Risk
28%
Toll-like Receptor 2 (TLR2)
28%
TLR6
28%
TLR1
28%
Tumor Necrosis Factor-α
14%
High Risk
14%
Interleukin-6
14%
Cell Population
14%
Receptor Signaling
14%
Inflammation
14%
Interleukin-8
14%
Bone Marrow Samples
14%
Healthy Controls
14%
Binding Partners
14%
Multiple Cell Types
14%
Receptor Agonist
14%
Cytokine Production
14%
Macrophage Inflammatory Protein 1α
14%
Therapeutic Strategies
14%
Low-risk Patients
14%
Granzyme B
14%
CD34+ Cells
14%
Immune Signaling
14%
Stem Cell Deficiency
14%
Low-risk Disease
14%
Mass Cytometry
14%
Multi-cell
14%
Bone Marrow Hematopoietic Cells
14%
Medicine and Dentistry
Cytokine
100%
Myelodysplastic Syndrome
100%
Toll Like Receptor
100%
Receptor Expression
62%
Hematopoietic Cell
50%
Toll Like Receptor 6
25%
Toll Like Receptor 2
25%
Toll Like Receptor 1
25%
Cancer Growth Factor
25%
Tumor Necrosis Factor
12%
Cell Population
12%
Interleukin 6
12%
Disease
12%
Cytokine Production
12%
Mass Cytometry
12%
Immunity
12%
Interleukin 8
12%
Granzyme B
12%
Toll Like Receptor Agonist
12%
Macrophage Inflammatory Protein 1
12%
Diseases
12%
Immunology and Microbiology
Cytokine
100%
Toll-Like Receptor
100%
Hematopoietic Cell
57%
TLR2
28%
TLR6
28%
TLR 1
28%
Cancer Growth Factor
28%
Tumor Necrosis Factor
14%
Cell Population
14%
Interleukin 6
14%
Agonist
14%
Macrophage Inflammatory Protein 1
14%
Immunity
14%
Granzyme B
14%
CD34
14%
Cytokine Production
14%
Mass Cytometry
14%
Interleukin 8
14%
Neuroscience
Toll-Like Receptor
100%
Receptor Expression
71%
Hematopoietic Cell
57%
TLR 2
28%
TLR6
28%
TLR 1
28%
Cancer Growth Factor
28%
Receptor Agonists
14%
Interleukin 6
14%
Necrosis
14%
CD34
14%
Cytokine Production
14%
Macrophage Inflammatory Protein 1
14%
Granzyme B
14%
Interleukin 8
14%